Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

UNITED STATES: HIV and Hepatitis C Co-infection Increases the Risk of Cornitive Impairment


AIDSMAP (12.11.12)

A study published in the Journal of Acquired Immune Deficiency Syndromes documented mild cognitive impairment in men who were coinfected with HIV and hepatitis C in comparison to groups of HIV-infected men, hepatitis C-infected men, and a control group of healthy men. In addition to more symptoms of depression, the coinfected group scored lower on tests for attention, executive function, fine motor function, and visual and verbal learning memory, AIDSMAP reported. When overall scores for each group were compared, the study ranked 65 percent of the coinfected men as cognitively “impaired.” The study classified 42 percent of men infected only with hepatitis C and 29 percent of HIV-infected men as impaired. Eighteen percent of the control group scored in the impaired range. Researchers from the United States Department of Veterans Affairs stated that all of the coinfected men in the study had well-controlled HIV with undetectable viral loads. None of the men had clinical depression, cirrhosis of the liver, or drug or alcohol abuse problems at the time of the study. The study, “Differential Cognitive Impairment in HCV Coinfected Men with Controlled HIV Compared to HCV Monoinfection,” was published online in the Journal of Acquired Immune Deficiency Syndrome (DOI: 10.1097/QAI.0b013e31827b61f1, 2012).


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in December 19, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.